14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $23.53 $28.69 Friday, 3rd May 2024 INSM stock ended at $25.55. This is 0.429% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.06% from a day low at $25.40 to a day high of $26.43.
90 days $23.53 $29.91
52 weeks $18.09 $32.00

Historical Insmed prices

Date Open High Low Close Volume
Mar 14, 2016 $12.00 $12.64 $11.96 $12.42 252 700
Mar 11, 2016 $11.99 $12.20 $11.75 $12.03 295 300
Mar 10, 2016 $12.26 $12.70 $11.43 $11.91 345 600
Mar 09, 2016 $12.53 $12.80 $11.61 $12.32 353 700
Mar 08, 2016 $13.25 $13.54 $12.39 $12.39 433 800
Mar 07, 2016 $12.39 $13.31 $12.12 $13.30 447 100
Mar 04, 2016 $12.58 $13.03 $12.28 $12.45 375 900
Mar 03, 2016 $12.86 $12.93 $12.33 $12.58 482 100
Mar 02, 2016 $11.72 $12.89 $11.56 $12.88 616 500
Mar 01, 2016 $12.28 $12.70 $11.49 $11.80 1 189 600
Feb 29, 2016 $12.38 $13.29 $12.04 $12.23 759 700
Feb 26, 2016 $11.63 $12.23 $11.42 $12.10 492 700
Feb 25, 2016 $12.42 $12.64 $11.49 $11.61 575 300
Feb 24, 2016 $12.31 $12.51 $11.84 $12.39 436 800
Feb 23, 2016 $13.13 $13.50 $12.49 $12.52 378 800
Feb 22, 2016 $13.17 $13.50 $13.06 $13.34 297 500
Feb 19, 2016 $12.62 $13.06 $12.37 $12.94 493 900
Feb 18, 2016 $13.52 $13.58 $12.67 $12.69 425 700
Feb 17, 2016 $13.46 $13.96 $13.39 $13.48 546 500
Feb 16, 2016 $13.27 $13.75 $13.16 $13.32 339 400
Feb 12, 2016 $12.96 $13.10 $12.44 $13.06 310 000
Feb 11, 2016 $12.46 $12.98 $11.99 $12.79 533 300
Feb 10, 2016 $13.01 $13.47 $12.65 $12.81 341 100
Feb 09, 2016 $12.03 $13.17 $11.89 $12.75 491 900
Feb 08, 2016 $12.46 $13.04 $12.07 $12.33 739 200
Click to get the best stock tips daily for free!

About Insmed

Insmed Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutr... INSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT